Subscribe To Our Free Newsletter |
Zydus Lifesciences receives USFDA approval for Isosorbide Mononitrate ER Tablets
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Isosorbide Mononitrate Extended-Release, Tablets USP, 30 mg, 60 mg, and 120 mg (USRLD: Imdur Extended-Release Tablets).